Company / Revenue per Share
Biofrontera Inc. Revenue per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.21
FY2025
5-year range
$2.36 / $28.18
FY2021-FY2025
Trend
-81.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 5 years, ranging from $2.36 in FY2021 to $28.18 in FY2022.
Based on SEC 10-K filings.
4.21 in FY2025 with a 3-year CAGR of -47.0%.
Declined from $21.48 to $4.21 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -47.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 81.3% year-over-year.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.21 | -81.3% |
| FY2024 | $22.45 | +4.5% |
| FY2023 | $21.48 | -23.8% |
| FY2022 | $28.18 | +1096.0% |
| FY2021 | $2.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026